Zusammenfassung
Eine Krebsdiagnose ist für Betroffene und ihre Angehörigen häufig mit damit einhergehenden psychischen Belastungen und mit wesentlichen Veränderungen der alltäglichen Lebensführung verbunden. Die psychoonkologische Versorgung hat das Ziel, der Belastung der Betroffenen und ihrer Angehörigen mit psychosozialen und psychotherapeutischen Mitteln entgegenzuwirken. Häufig äußert sich die Belastung in Form von Ängsten, die je nach Situation und Krankheitsverlauf inter- und intraindividuell teilweise stark variieren und zudem über die Remission einer Krebserkrankung hinweg fortbestehen können. Für die psychoonkologische Beratung und Therapie ist es daher wichtig, pathologische von nichtpathologischen Ängsten differenzieren zu können sowie Informationen über verschiedene Facetten von Angst im onkologischen Kontext und im Krankheitsverlauf zu kennen. Verschiedene Emotionsregulationsstrategien sind als probates Mittel etabliert, um Ängsten von Patienten zu begegnen. Die Theorie der Emotionsregulation liefert ein hilfreiches Gerüst zur Ableitung indizierter Beratungstechniken und therapeutischer Interventionen. Auch für die psychoonkologische Versorgung – mit ihrem hohen Anspruch an Individualität und Flexibilität – bietet die Wahl der jeweils besten Emotionsregulationsstrategien die Chance, optimal auf Ängste und Angstsymptome von Krebspatienten als auch deren Angehörigen reagieren zu können.
Abstract
A diagnosis of cancer is often associated with substantial changes in everyday life and with psychological distress for afflicted individuals and their relatives. Psycho-oncological patient care aims to reduce the distress of afflicted individuals and their relatives by using psychosocial and psychotherapeutic techniques. Cancer-related distress often results in anxieties, which vary interindividually and intraindividually depending on the patient’s situation and course of the disease and can even continue after remission from cancer. Thus, it is essential for psycho-oncological consultation and therapy to be able to differentiate between pathological and non-pathological anxieties and to be aware of different facets of anxiety in the oncological context and during the course of the disease. Various emotion regulation strategies have been established as useful tools to address patient anxiety. The theory of emotion regulation provides a useful framework for the selection of counseling techniques and therapeutic interventions. Accordingly, in psycho-oncological consultation, with its high requirement of individuality and flexibility, the individual selection of emotion regulation strategies offers the opportunity to optimally react to anxieties and anxiety symptoms of cancer patients and their relatives.
Notes
Diagnostic and Statistical Manual of Mental Disorders, 5. Aufl.
Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Ausg.
Literatur
Ávila M, Brandão T, Teixeira J et al (2015) Attachment, emotion regulation, and adaptation to breast cancer: assessment of a mediational hypothesis. Psychooncology 24:1514–1520
Badr H, Krebs P (2013) A systematic review and meta-analysis of psychosocial interventions for couples coping with cancer. Psychooncology 22:1688–1704
Bandelow B, Wiltink J, Alpers GW et al (2014) Deutsche S3-Leitlinie Behandlung von Angststörungen. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, Düsseldorf
Bender CM, Gentry AL, Casillo FE et al (2014) Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol Nurs Forum 41:274–285
Brandão T, Tavares R, Schulz MS et al (2015) Measuring emotion regulation and emotional expression in breast cancer patients: a systematic review. Clin Psychol Rev 43:114–127
Brown AJ, Shen MJ, Ramondetta LM et al (2014) Does death anxiety affect end-of-life care discussions? Int J Gynecol Cancer 24:1521–1526
Bundesministerium Für Gesundheit (2017) Nationaler Krebsplan: Handlungsfelder, Ziele, Umsetzungsempfehlungen und Ergebnisse. Bundesministerium für Gesundheit, Bonn
Butow P, Kelly S, Thewes B et al (2015) Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence. Psychooncology 24:416–423
Butow P, Sharpe L, Thewes B et al (2018) Fear of cancer recurrence: a practical guide for clinicians. Oncol J 32:32–38
Butow PN, Turner J, Gilchrist J et al (2017) Randomized trial of ConquerFear: a novel, theoretically based psychosocial intervention for fear of cancer recurrence. J Clin Oncol 35:4066–4077
Cameron LD, Booth RJ, Schlatter M et al (2007) Changes in emotion regulation and psychological adjustment following use of a group psychosocial support program for women recently diagnosed with breast cancer. Psychooncology 16:171–180
Conley CC, Bishop BT, Andersen BL (2016) Emotions and emotion regulation in breast cancer survivorship. Healthcare (Basel) 4(3):E56. https://doi.org/10.3390/healthcare4030056
Consedine NS, Magai C, Krivoshekova YS et al (2004) Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev 13:501–510
Crist JV, Grunfeld EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology 22:978–986
Cupit-Link M, Syrjala KL, Hashmi SK (2018) Damocles’ syndrome revisited: Update on the fear of cancer recurrence in the complex world of today’s treatments and survivorship. Hematol Oncol Stem Cell Ther. https://doi.org/10.1016/j.hemonc.2018.01.005
Curran L, Sharpe L, Butow P (2017) Anxiety in the context of cancer: a systematic review and development of an integrated model. Clin Psychol Rev 56:40–54
Dekker J, Braamse A, Schuurhuizen C et al (2017) Distress in patients with cancer—on the need to distinguish between adaptive and maladaptive emotional responses. Acta Oncol 56:1026–1029
Deutsche Krebsgesellschaft, Deutsche Krebshilfe, Awmf (2014) S3-Leitlinie: Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten
Die Trill M (2013) Anxiety and sleep disorders in cancer patients. EJC Suppl 11:216–224
Dimatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101–2107
Dinkel A, Kremsreiter K, Marten-Mittag B et al (2014) Comorbidity of fear of progression and anxiety disorders in cancer patients. Gen Hosp Psychiatry 36:613–619
Faller H, Schuler M, Richard M et al (2013) Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol 31:782–793
Ferrer RA, Green PA, Barrett LF (2015) Affective science perspectives on cancer control: strategically crafting a mutually beneficial research agenda. Perspect Psychol Sci 10:328–345
Greer JA, Pirl WF, Park ER et al (2008) Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 65:549–552
Greer JA, Macdonald J, Traeger L (2015) Anxiety disorders. In: Holland JC, Breitbart WS, Butow PN, Jacobsen PB, Loscalzo MJ, McCorkle R (Hrsg) Psycho-oncology. Oxford University Press, Oxford, S 296–303
Gross JJ (1989) Emotional expression in cancer onset and progression. Soc Sci Med 28:1239–1248
Gross JJ, Jazaieri H (2014) Emotion, emotion regulation, and psychopathology: an affective science perspective. Clin Psychol Sci 2:387–401
Gross JJ, Thompson RA (2007) Emotion regulation: conceptual foundations. In: Gross JJ (Hrsg) Handbook of emotion regulation. Guilford, New York, London, S 3–24
Heinrichs N, Zimmermann T, Huber B et al (2012) Cancer distress reduction with a couple-based skills training: a randomized controlled trial. Ann Behav Med 49:239–252
Herrmann-Lingen C, Buss U, Snaith RP (2011) Hospital Anxiety and Depression Scale (HADS) – Deutsche Version: Deutsche Adaptation der Hospital Anxiety and Depression Scale (HADS) von R. P. Snaith und A. S. Zigmond. Hogrefe, Göttingen
Hodges LJ, Walker J, Kleiboer AM et al (2011) What is a psychological intervention? A metareview and practical proposal. Psychooncology 20:470–478
Hornemann B, Schuler U (2017) Krebs – zum Fürchten!? Wann wird Angst pathologisch. Nervenheilkunde 36:955–962
Hoyt MA, Nelson CJ, Darabos K et al (2017) Mechanisms of navigating goals after testicular cancer: meaning and emotion regulation. Psychooncology 26:747–754
Iverach L, Menzies RG, Menzies RE (2014) Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct. Clin Psychol Rev 34:580–593
Jacobsen PB, Donovan KA, Trask PC et al (2005) Screening for psychologic distress in ambulatory cancer patients: a multicenter evaluation of the distress thermometer. Cancer 103:1494–1502
Kangas M, Gross JJ (2017) The affect regulation in cancer framework: understanding affective responding across the cancer trajectory. J Health Psychol. https://doi.org/10.1177/1359105317748468
Koch L, Jansen L, Brenner H et al (2013) Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors—a systematic review of quantitative studies. Psychooncology 22:1–11
Kusch M, Labouvie H, Hein-Nau B (2013) Klinische Psychoonkologie. Springer, Berlin, Heidelberg
Kusch M, Labouvie H, Gerlach A et al (2016) Kommt die personalisierte Psychoonkologie? TumorDiagn Ther 37:560–564
Lebel S, Ozakinci G, Humphris G et al (2016) From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 24:3265–3268
Lewis F, Merckaert I, Liénard A et al (2014a) Anxiety and its time courses during radiotherapy for non-metastatic breast cancer: a longitudinal study. Radiother Oncol 111:276–280
Lewis F, Merckaert I, Liénard A et al (2014b) Anxiety at the first radiotherapy session for non-metastatic breast cancer: key communication and communication-related predictors. Radiother Oncol 114:35–41
Lim CC, Devi MK, Ang E (2011) Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc 9:215–235
Linden W, Vodermaier A, Mackenzie R et al (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141:343–351
Matthews H, Grunfeld EA, Turner A (2017) The efficacy of interventions to improve psychosocial outcomes following surgical treatment for breast cancer: a systematic review and meta-analysis. Psychooncology 26:593–607
Mehnert A, Lehmann C, Koch U (2006) Prävalenz und Diagnostik psychischer Störungen in der Onkologie. Onkologe 12:18–26
Mitchell AJ, Meader N, Symonds P (2010) Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. J Affect Disord 126:335–348
Mitchell AJ, Chan M, Bhatti H et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12:160–174
Molassiotis A, Lee PH, Burke TA et al (2016) Anticipatory nausea, risk factors, and its impact on chemotherapy-induced nausea and vomiting: results from the Pan European Emesis Registry Study. J Pain Symptom Manage 51:987–993
Neel C, Lo C, Rydall A et al (2015) Determinants of death anxiety in patients with advanced cancer. BMJ Support Palliat Care 5:373–380
Osborn RL, Demoncada AC, Feuerstein M (2006) Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med 36:13–34
O’toole MS, Zachariae R, Renna ME et al (2017) Cognitive behavioral therapies for informal caregivers of patients with cancer and cancer survivors: a systematic review and meta-analysis. Psychooncology 26:428–437
Peh CX, Liu J, Bishop GD et al (2017) Emotion regulation and emotional distress: the mediating role of hope on reappraisal and anxiety/depression in newly diagnosed cancer patients. Psychooncology 26:1191–1197
Piet J, Würzten H, Zachariae R (2012) The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol 80:1007–1020
Prinz-Zaiss M (2017) Perspektiven der Niedergelassenen Psychotherapeuten in der Psychoonkologie. Nervenheilkunde 36:969–971
Reed RG, Weihs KL, Sbarra DA et al (2016) Emotional acceptance, inflammation, and sickness symptoms across the first two years following breast cancer diagnosis. Brain Behav Immun 56:165–174
Roth AJ, Kornblith AB, Batel-Copel L et al (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82:1904–1908
Rudolph B, Wünsch A, Herschbach P et al (2018) Ambulante verhaltenstherapeutische Gruppentherapie zur Behandlung von Progredienzangst bei Krebspatienten. Psychother Psychosom Med Psychol 68:38–43
Schlatter MC, Cameron LD (2010) Emotional suppression tendencies as predictors of symptoms, mood, and coping appraisals during AC chemotherapy for breast cancer treatment. Ann Behav Med 40:15–29
Simonelli LE, Siegel SD, Duffy NM (2017) Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology 26:1444–1454
Singer S, Bringmann H, Hauss J et al (2007) Häufigkeit psychischer Begleiterkrankungen und der Wunsch nach psychosozialer Unterstützung bei Tumorpatienten im Akutkrankenhaus. Dtsch Med Wochenschr 132:2071–2076
Singer S, Beckerle J, Kleining B et al (2017) „Die Strukturen müssen viel flexibler sein“. Qualitative Befragung niedergelassener Psychotherapeuten zur Versorgung von Krebspatienten. Psychotherapeut 62:440–449
Tamagawa R, Giese-Davis J, Speca M et al (2013) Trait mindfulness, repression, suppression, and self-reported mood and stress symptoms among women with breast cancer. J Clin Psychol 69:264–277
Vehling S, Koch U, Ladehoff N et al (2012) Prävalenz affektiver und Angststörungen bei Krebs: Systematischer Literaturreview und Metaanalyse. Psychother Psychosom Med Psychol 62:249–258
Waadt S, Duran G, Berg P et al (2011) Progredienzangst – Manual zur Behandlung von Zukunftsängsten bei chronisch Kranken. Schattauer, Stuttgart
Yu Y, Peng L, Tang T et al (2014) Effects of emotion regulation and general self-efficacy on posttraumatic growth in Chinese cancer survivors: assessing the mediating effect of positive affect. Psychooncology 23:473–478
Zhang M‑F, Wen Y‑S, Liu W‑Y et al (2015) Effectiveness of mindfulness-based therapy for reducing anxiety and depression in patients with cancer: a meta-analysis. Medicine (Baltimore) 94:e897
Zimmermann T, Heinrichs N, Scott JL (2006) CanCOPE „Schritt für Schritt“. Die Effektivität eines partnerschaftlichen Unterstützungsprogramms bei Frauen mit Brust- oder gynäkologischen Krebserkrankungen. Verhaltenstherapie 16:247–255
Zimmermann T, Heinrichs N, Baucom DH (2007) “Does one size fit all?” Moderators in psychosocial interventions for breast cancer patients: a meta-analysis. Ann Behav Med 34:225–239
Zimmermann T, Alsleben M, Heinrichs N (2012) Progredienzangst gesunder Lebenspartner von chronisch erkrankten Patienten. Psychother Psychosom Med Psychol 62:344–351
Förderung
Die Erstellung des Beitrags wurde teilweise vom Innovationsfond des Gemeinsamen Bundesausschusses in Form des Projekts „isPO – Integrierte, sektorenübergreifende Psychoonkologie“ gefördert (Förderkennzeichen 01NVF17022-IsPo).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Bussmann, L. Vaganian, M. Kusch, H. Labouvie, A.L. Gerlach und J.C. Cwik geben an, dass kein Interessenkonflikt besteht.
Für diese Übersichtsarbeit wurden keine Studien an Menschen oder Tieren durchgeführt.
Additional information
Redaktion
Alexandra Martin, Wuppertal
Alexander Gerlach, Köln
Sonja Bussmann und Lusine Vaganian teilen sich die Erstautorenschaft.
Aus Gründen der Lesefreundlichkeit wird in diesem Beitrag das generische Maskulinum verwendet.
Rights and permissions
About this article
Cite this article
Bussmann, S., Vaganian, L., Kusch, M. et al. Angst und Emotionsregulation bei Krebspatienten. Psychotherapeut 63, 194–203 (2018). https://doi.org/10.1007/s00278-018-0283-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00278-018-0283-3